Hae Jin Kim Selected Research

Hae Jin Kim Research Topics

Disease

31	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2004
24	Insulin Resistance 01/2020 - 04/2004
11	Inflammation (Inflammations) 09/2021 - 01/2011
8	Obesity 01/2021 - 06/2008
7	Body Weight (Weight, Body) 01/2018 - 06/2006
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2022 - 04/2004
5	Non-alcoholic Fatty Liver Disease 01/2022 - 10/2004
5	Diabetes Complications 01/2022 - 05/2012
5	Hyperglycemia 01/2020 - 10/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 12/2004
4	Neoplasms (Cancer) 01/2020 - 02/2018
4	Ganglion Cysts (Ganglion) 08/2017 - 09/2016
4	Atherosclerosis 01/2017 - 11/2010
4	Glucose Intolerance 01/2017 - 03/2009
3	Fibrosis (Cirrhosis) 01/2022 - 06/2020
3	Fatty Liver 09/2021 - 11/2016
3	Heart Failure 01/2020 - 09/2017
3	Dementia (Dementias) 01/2020 - 12/2018
3	Hypertension (High Blood Pressure) 05/2017 - 11/2014
3	Hypoxia (Hypoxemia) 01/2016 - 01/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 09/2021
2	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 11/2016
2	Coronary Disease (Coronary Heart Disease) 01/2022 - 12/2004
2	Pain (Aches) 02/2018 - 07/2013
2	Renal Cell Carcinoma (Grawitz Tumor) 02/2018 - 09/2016
2	Glaucoma 07/2017 - 01/2017
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 04/2004
2	Abdominal Obesity 01/2017 - 01/2011
2	Hypertrophy 11/2016 - 05/2007
2	Albuminuria 01/2016 - 01/2015
1	Lymphedema (Milroy Disease) 10/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Alcoholic Fatty Liver 01/2022
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2022

Drug/Important Bio-Agent (IBA)

21	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 06/2006
8	Triglycerides (Triacylglycerol)IBA 01/2022 - 04/2004
8	PalmitatesIBA 01/2020 - 11/2010
7	Insulin (Novolin)FDA Link 01/2022 - 08/2006
7	Dipeptidyl-Peptidase IV InhibitorsIBA 11/2021 - 01/2016
6	CytokinesIBA 01/2022 - 06/2008
5	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 01/2008
5	Nicotinamide PhosphoribosyltransferaseIBA 09/2021 - 12/2011
5	AdiponectinIBA 01/2019 - 06/2008
5	Nonesterified Fatty Acids (NEFA)IBA 01/2019 - 05/2007
5	LipidsIBA 01/2018 - 10/2006
5	Rosiglitazone (Avandia)FDA Link 07/2008 - 06/2006
4	AdipokinesIBA 09/2021 - 06/2008
4	SodiumIBA 01/2021 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2007
4	Retinaldehyde (Retinal)IBA 08/2017 - 09/2016
4	C-Reactive ProteinIBA 01/2017 - 04/2004
4	CholesterolIBA 06/2011 - 10/2006
3	FructoseIBA 01/2022 - 11/2016
3	Interleukin-6 (Interleukin 6)IBA 01/2019 - 06/2008
3	Pharmaceutical PreparationsIBA 04/2018 - 10/2011
3	Metformin (Glucophage)FDA LinkGeneric 02/2018 - 02/2011
3	CreatinineIBA 05/2017 - 12/2006
3	fibroblast growth factor 21IBA 07/2016 - 05/2012
3	oxidized low density lipoproteinIBA 09/2013 - 10/2006
3	HDL CholesterolIBA 10/2006 - 04/2004
2	Hematoxylin (Haematoxylon)IBA 01/2022 - 11/2016
2	InterleukinsIBA 01/2022 - 06/2008
2	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 06/2008
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 11/2016
2	EnzymesIBA 01/2022 - 01/2011
2	ChemokinesIBA 01/2022 - 06/2020
2	Choline (Choline Chloride)IBA 01/2022 - 09/2021
2	LC15-0444IBA 01/2022 - 11/2018
2	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 11/2021 - 08/2019
2	SymportersIBA 01/2021 - 01/2018
2	dapagliflozinIBA 01/2021 - 01/2020
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2019 - 10/2011
2	ORALIT (ORS)IBA 01/2019 - 04/2004
2	Messenger RNA (mRNA)IBA 01/2019 - 05/2007
2	IronIBA 01/2019 - 05/2015
2	CalciumIBA 01/2019 - 01/2017
2	AlbuminsIBA 05/2017 - 01/2016
2	Blood Glucose (Blood Sugar)IBA 11/2016 - 06/2011
2	Adrenergic Agents (Adrenergic Drugs)IBA 01/2016 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 09/2013 - 04/2011
2	LDL CholesterolIBA 09/2013 - 10/2006
2	Testosterone (Sustanon)FDA Link 12/2011 - 04/2011
2	LDL Lipoproteins (beta Lipoproteins)IBA 04/2011 - 10/2006
2	LeptinIBA 07/2008 - 06/2008
2	Perilipin-1IBA 05/2007 - 06/2006
1	Adenosine Triphosphate (ATP)IBA 10/2022
1	alogliptinIBA 01/2022
1	Galectin 3 (LGALS3)IBA 01/2022
1	Pioglitazone (Actos)FDA Link 01/2022
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2022
1	AntioxidantsIBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	empagliflozinIBA 01/2022

Therapy/Procedure

5	Therapeutics 01/2022 - 09/2013
5	Glycemic Control 08/2019 - 09/2013
2	Radiofrequency Ablation 02/2018 - 09/2016
2	Aftercare (After-Treatment) 05/2017 - 01/2016